Hypereosinophilic syndrome posttreatment with triple-negative breast cancer
Therapy-related secondary hematological changes play a crucial role in determining the life span of an otherwise recovered cancer patient after successful treatment. Hypereosinophilic syndrome (HES) is a potentially life-threatening condition when left unmanaged. The exact etiology of HES, however,...
Main Author: | Khalid A AlSaleh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Applied Hematology |
Subjects: | |
Online Access: | http://www.jahjournal.org/article.asp?issn=1658-5127;year=2020;volume=11;issue=2;spage=80;epage=83;aulast=AlSaleh |
Similar Items
-
Hypereosinophilic syndromes
by: Giuseppe Civardi, et al.
Published: (2013-04-01) -
Hypereosinophilic syndrome with cardiac and neurological involvement in the setting of FIP1L1-PDGFRA-gene rearrangement
by: W. A. Y. C. Piyarathna, et al.
Published: (2025-03-01) -
Loeffler’s Endocarditis – Unforgiving Eosinophilic Damage to the Endocardium
by: Ajay Sinha, et al.
Published: (2024-12-01) -
Salvage therapy of imatinib-resistant hypereosinophilic syndrome with PDGFRB rearrangement
by: Miao-Erh Chang, et al.
Published: (2016-03-01) -
Eosinophilic myocarditis and hypereosinophilic syndrome
by: Hanane Boussir, et al.
Published: (2017-07-01)